Other News To Note
Wednesday, May 29, 2013
Flamel Technologies Inc., of Lyon, France, said it exercised its right to regain control of two drugs that use its Trigger lock delivery technology that formerly were being developed in partnership with an undisclosed partner. Trigger Lock is an abuse-resistant technology for long-acting opioid analgesics.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.